Phone
800.277.1193Randy Boyd’s CPAP Nightmare: How Philips Respironics’ sleep apnea treatment device took one user from a sleep disorder to cancer
In 2016, Randy Boyd thought his dreams had come true. He was prescribed a Philips Respironics CPAP device to help him with his sleep apnea.
From the onset, the device was a game changer.
Philips Recall of Millions of CPAP Devices Creates National Health Crisis
Recently, the Journal of the American Medical Association published an article that addressed the national health crisis created by Philips and their June 2021 recall of more than 10 million CPAP, BiPAP, and Ventilator devices in the United States.
The recall has affected millions of people across the U.S. who now worry about the impact the recalled devices may have had on their long-term health.
FDA Got Tired of Waiting for Philips to Do the Right Thing with CPAP—So They’re Making Them Do It
The U.S. Food and Drug Administration (FDA) has called out Philips Respironics for its inadequate efforts in notifying patients, suppliers, and healthcare providers of a massive recall of some of the company’s breathing assistance devices. On March 10, 2022, the agency ordered the company to notify these users of the recall and the products’ risks.
LPR Partner Virginia Buchanan Appointed to Plaintiffs Leadership Team in Philips CPAP MDL
Attorney Buchanan said she looks forward to bringing justice to those who have suffered from the defective medical devices.
Philips' CPAP Repair Plan Could Take A Year to Wrap Up
The company further informs that it has produced around 750,000 replacement devices and repair kits. More than 250,000 are actually in consumers’ hands.
The delay in receiving new devices has been a point of frustration for users.
Panel Considers Consolidating CPAP Lawsuits
As of September 28, 2021, a total of 93 class actions had been filed against Continuous Positive Air Pressure (CPAP) maker Philips Respironics. The Judicial Panel on Multidistrict Litigation announced it will hear motions to consolidate or coordinate pretrial proceedings for these lawsuits.
Philips Recalls V60 Plus Ventilators Equipped With High Flow Therapy
The U.S. Food and Drug Administration (FDA) issued notice that Philips Respironics recalled its V60 Plus Ventilators Equipped with High Flow Therapy (software version 3.00 and 3.10) and all V60 ventilators that have been upgraded to enable High Flow Therapy with this software. The manufacturer distributed the affected devices between May 1, 2009, and June 2, 2021.
Philips CPAP Recall - Degradation of Foam Could Cause Cancer and Other Health Risks
Phillips Respironics has issued a voluntary recall of around 4 million CPAP and BiLevel PAP devices. According to the manufacturer’s notification, the company’s quality management system revealed these products pose serious health risks and potentially life-threatening injuries for users.
The first-generation DreamStation product family comprises the Philips medical devices most affected by the recall.